JP2007513903A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513903A5
JP2007513903A5 JP2006543431A JP2006543431A JP2007513903A5 JP 2007513903 A5 JP2007513903 A5 JP 2007513903A5 JP 2006543431 A JP2006543431 A JP 2006543431A JP 2006543431 A JP2006543431 A JP 2006543431A JP 2007513903 A5 JP2007513903 A5 JP 2007513903A5
Authority
JP
Japan
Prior art keywords
permeation enhancer
composition
composition according
aliphatic fatty
terpene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006543431A
Other languages
English (en)
Japanese (ja)
Other versions
JP4842141B2 (ja
JP2007513903A (ja
Filing date
Publication date
Priority claimed from DE10358525A external-priority patent/DE10358525A1/de
Application filed filed Critical
Publication of JP2007513903A publication Critical patent/JP2007513903A/ja
Publication of JP2007513903A5 publication Critical patent/JP2007513903A5/ja
Application granted granted Critical
Publication of JP4842141B2 publication Critical patent/JP4842141B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006543431A 2003-12-13 2004-11-30 皮膚適用のための殺内寄生生物組成物 Expired - Fee Related JP4842141B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation
DE10358525.7 2003-12-13
PCT/EP2004/013552 WO2005055973A2 (de) 2003-12-13 2004-11-30 Endoparasitizide mittel zur topischen applikation

Publications (3)

Publication Number Publication Date
JP2007513903A JP2007513903A (ja) 2007-05-31
JP2007513903A5 true JP2007513903A5 (https=) 2008-01-17
JP4842141B2 JP4842141B2 (ja) 2011-12-21

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006543431A Expired - Fee Related JP4842141B2 (ja) 2003-12-13 2004-11-30 皮膚適用のための殺内寄生生物組成物

Country Status (31)

Country Link
US (1) US7763583B2 (https=)
EP (1) EP1694291B1 (https=)
JP (1) JP4842141B2 (https=)
KR (1) KR101272139B1 (https=)
CN (1) CN1893919B (https=)
AR (1) AR046878A1 (https=)
AT (1) ATE447940T1 (https=)
AU (1) AU2004296537B2 (https=)
BR (1) BRPI0417578B1 (https=)
CA (1) CA2548897C (https=)
CR (1) CR8428A (https=)
DE (2) DE10358525A1 (https=)
DK (1) DK1694291T3 (https=)
ES (1) ES2334920T3 (https=)
GT (1) GT200400264A (https=)
HR (1) HRP20100056T1 (https=)
IL (1) IL176151A (https=)
MX (1) MXPA06006594A (https=)
MY (1) MY142044A (https=)
NO (1) NO20063171L (https=)
NZ (1) NZ547837A (https=)
PE (1) PE20050919A1 (https=)
PL (1) PL1694291T3 (https=)
PT (1) PT1694291E (https=)
RU (1) RU2401108C2 (https=)
SI (1) SI1694291T1 (https=)
TW (1) TWI341202B (https=)
UA (1) UA85574C2 (https=)
UY (1) UY28662A1 (https=)
WO (1) WO2005055973A2 (https=)
ZA (1) ZA200604744B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Iii リミテッド 強化剤を含む固体経口投与剤形
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010042395A1 (en) * 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
CA2751854A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
CN104023710A (zh) * 2011-12-21 2014-09-03 拜耳知识产权有限责任公司 包含无定形艾默德斯的制剂
BR112015014266B1 (pt) * 2012-12-18 2021-01-26 Donaghys Limited formulação parasiticida transdermal na forma de uma solução
KR20160115993A (ko) * 2014-02-14 2016-10-06 디에스엠 아이피 어셋츠 비.브이. 주혈흡충병의 예방 및/또는 치료를 위한 조성물 및 방법
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー/エス Glp-1アゴニスト及び腸溶コーティングを含む錠剤
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
BR112018013369A2 (pt) 2015-12-28 2019-02-19 Merial, Inc. compostos depsipeptídicos anti-helmínticos
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
IL274283B2 (en) 2017-11-07 2025-03-01 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
KR20020058023A (ko) * 1999-11-18 2002-07-12 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 살충성 아미노헤테로시클릴아미드 화합물
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
ES2258062T3 (es) 2000-10-10 2006-08-16 Wyeth Composicion antihelmintica.
NZ526538A (en) * 2000-12-20 2005-12-23 Novartis Ag Anti-endoparasitic amidoacetonitrils
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
BRPI0409185B1 (pt) * 2003-04-04 2018-05-15 Merial, Inc Formulações veterinárias anti-helmínticas tópicas

Similar Documents

Publication Publication Date Title
JP2007513903A5 (https=)
CA2548897A1 (en) Endoparasiticidal agents for topical application
US9707187B2 (en) Composition for enhancing transdermal absorption of a drug and patch preparation
JP2009533335A5 (https=)
WO2011146936A3 (en) Self-assembled surfactant structures
ECSP034430A (es) Esteres oxigenados de acidos 4-yodo fenilamino benzhidroxamcios
AU2001279631A1 (en) Self-emulsifying active substance formulation and use of this formulation
NZ600721A (en) Capsule formulation
WO2007063332A3 (en) Laser-imageable marking compositions
BRPI0414096A (pt) sistema lipìdico e métodos de uso
TW200631597A (en) External use preparation and adhesive preparation thereof
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
WO2007133265A3 (en) Adhesive with alkanoate blend
WO2008149035A3 (fr) Nouveau principe actif dans la cicatrisation et son utilisation
ATE413865T1 (de) Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür
CA2845165C (en) Composition for enhancing transdermal absorption of drug and patch preparation
WO2007031753A3 (en) Topical film-forming monophasic formulations
JP2002514648A5 (https=)
ATE395050T1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
RU2006122181A (ru) Система трансдермальной доставки никотина
EP2177531A3 (en) Cell permeable peptide
UA88310C2 (ru) Твердое формированное изделие, содержащее активное вещество, для внешнего применения против паразитов у животных
EP2570116B1 (en) Composition for enhancing transdermal absorption of a drug and patch preparation
CA2599334A1 (en) External plaster containing flurbiprofen
WO2006062933A3 (en) Stable compositions of fenofibrate with fatty acid esters